Skip to content

Artificial intelligence-based natural language processing technology reduces relapse rate and disease burden of major mental disorders: A Randomized Clinical Trial

Research on possible methods to reduce the recurrence rate and disease burden of major mental disorders based on natural language processing technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097033
Enrollment
Unknown
Registered
2025-02-11
Start date
2024-03-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental disorders

Interventions

Non-knowledge question and answer model, self-assessment scale, and follow-up model group:Allow patients to take medication at home without providing knowledge question and answer model, follow-up mo
Non-knowledge QA model and self-assessment scale ,provided follow-up model group:Allow patients to take medicine at home, do not provide knowledge QA model and self-assessment scale, but provide a fol
Non-knowledge QA model and follow-up model, provided self-assessment scale group:Allow patients to take medicine at home, do not provide knowledge QA model and follow-up model, but provide self-asses
Non-knowledge QA model,provided follow-up model and self-assessment scale group:Allow patients to take medicine at home, do not provide knowledge QA model, but provide self-assessment scale and follow
Non-self-assessment scale,provided knowledge QA model and follow-up model group:Allow patients to take medication at home, do not provide self-assessment scale, but provide knowledge QA model and fo
Non- follow-up model,provided knowledge QA model and self-assessment scale group:Allow patients to take medicine at home, do not provide

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-65 years old; (2) Meet the diagnostic criteria for psychiatric-related diseases in ICD-10 (including major depressive disorder, bipolar disorder, and schizophrenia, etc.); (3) Patients who have recently experienced an illness and whose condition has improved and stabilized after treatment; (4) Sign the informed consent form for enrollment.

Exclusion criteria

Exclusion criteria: (1) The age is not in the range of 18-65 years old; (2) Does not meet the diagnostic criteria for psychiatry related diseases in ICD-10 (mainly including major depressive disorder, bipolar disorder, and schizophrenia); (3) Do not agree to sign the enrollment informed consent form.

Design outcomes

Primary

MeasureTime frame
Relapse hospitalization rate;Self discontinuation rate;Follow-up interruption rate;

Secondary

MeasureTime frame
SSFPI Scale score;TESS Scale score;Follow-up service evaluation satisfaction;

Countries

China

Contacts

Public ContactGaohua Wang

Renmin Hospital of Wuhan University

wgh6402@whu.edu.cn+86 133 0719 2798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026